Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 2020 Sep 17;86(10):2102. doi: 10.1111/bcp.14452

Withdrawn: Effectiveness and safety of toripalimab, camrelizumab and sintilimab in a real‐world cohort of hepatitis B virus associated hepatocellular carcinoma patients

Guosheng Yuan 1, Xiaoyun Hu 1, Qi Li 1, Wencong Dai 1, Xiao Cheng 1, Pengfei Ying 1, Wenxuan Yu 1, Yabing Guo 1, Mian Chen 2, Jinzhang Chen 1,
PMCID: PMC7495274  PMID: 32627214

Abstract

The above article from British Journal of Clinical Pharmacology, published online on July 5, 2020 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn by agreement among the authors and John Wiley & Sons Ltd on behalf of the British Pharmacology Society. The withdrawal has been agreed in accordance with the authors' decision to revise their study providing the latest data.


Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES